Family History of Blood Clot and Combined Contraceptives
A family history of venous thromboembolism in a first-degree relative before age 60 years is a relative contraindication to combined hormonal contraception, not an absolute contraindication—but progestin-only methods should be the first-line choice for these women. 1
Clinical Approach
Risk Stratification by Family History
The key determinant is age of the affected first-degree relative when the VTE occurred:
- Before age 60 years: Combined estrogen-progestin contraception is a relative contraindication 1
- Before age 50 years: Some guidelines use this more conservative threshold 1
- Before age 45 years: UK guidelines use this cutoff 2
Evidence on Risk Magnitude
Family history substantially increases VTE risk when combined with hormonal contraception:
- Family history alone confers an OR of 2.38 for VTE 3
- Combined oral contraceptive use alone confers an OR of 2.53 3
- The combination yields an OR of 6.02 (5.02-7.22) for VTE 3
- Importantly, there is no significant interaction between these risk factors—the risks multiply rather than synergize 3
Recommended Contraceptive Strategy
First-line options for women with positive family history:
- Microdose or macrodose progestin-only pills (desogestrel, norethisterone, levonorgestrel) 1
- Levonorgestrel intrauterine device (IUD) - no increased VTE risk (RR 0.61,95% CI 0.24-1.53) 4
- Copper IUD - highly effective with no thrombotic risk 4, 5
- Subdermal progestin implant (etonogestrel) - appears safe but limited data 4, 6
Avoid:
- All combined hormonal contraceptives (pills, patches, vaginal rings) 1
- Depot medroxyprogesterone acetate (DMPA) - may increase VTE risk (OR 2.19-2.67) 1, 4, 6
When Thrombophilia Testing is Indicated
Screening should be limited to women with first-degree family history of VTE before age 60 1. If testing is pursued, include:
- Prothrombin time (PT)
- Activated partial thromboplastin time (aPTT)
- Antithrombin levels
- Protein C and S levels
- Factor V Leiden mutation
- Prothrombin (FII) 20210A mutation 1
Routine screening before prescribing contraception is NOT recommended in women without family history 1, 5.
Important Clinical Caveats
What Does NOT Contraindicate Hormonal Contraception
- Superficial venous thrombosis (personal history) does not contraindicate hormonal contraception 1
- Family history in relatives beyond first-degree
- Family history of VTE occurring after age 60 years
Real-World Prescribing Patterns
Studies show that 18.9-25.9% of combined hormonal contraceptive prescriptions may be inappropriate when considering family history 2. Compliance with guidelines considering family history could prevent 13.5-18.5% of VTEs in CHC users 2. This suggests that family history is often overlooked or underweighted in clinical practice.
The Relative vs. Absolute Distinction Matters
The designation as a "relative" rather than "absolute" contraindication means that in exceptional circumstances—after thorough counseling about the 6-fold increased risk and consideration of all alternatives—combined hormonal contraception could theoretically be used 1. However, the clinical reality is that safer, equally effective alternatives exist, making this choice difficult to justify in routine practice.
Age Considerations
The thrombotic risk of combined hormonal contraceptives increases significantly with age, particularly beyond 40 years 1, 7. Women with family history who are also older face compounded risk and should be strongly steered toward progestin-only or non-hormonal methods.